AKT regulates many processes, including metabolism, proliferation, cell survival, growth, and angiogenesis, and targeting the PI3K/AKT signal pathway effectively treats asthma and IPF [57, 58]. This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.